Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Conformis Inc (CFMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
Docs: "Conformis Reports Second Quarter 2023 Financial Results"
03/01/2023 8-K Quarterly results
Docs: "Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results"
11/02/2022 8-K Quarterly results
Docs: "Conformis Reports Third Quarter 2022 Financial Results"
08/08/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
03/02/2022 8-K Quarterly results
11/03/2021 8-K Quarterly results
Docs: "Conformis Reports Third Quarter 2021 Financial Results"
08/04/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "Conformis Reports Third Quarter 2020 Financial Results"
08/05/2020 8-K Quarterly results
Docs: "Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers"
05/11/2020 8-K Quarterly results
Docs: "Conformis Reports First Quarter 2020 Financial Results BILLERICA, Mass., May 11, 2020 - Conformis, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2020. First Quarter 2020 Summary"
03/05/2020 8-K/A Quarterly results
03/02/2020 8-K Quarterly results
10/30/2019 8-K Quarterly results
07/31/2019 8-K Quarterly results
Docs: "Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations BILLERICA, Mass., July 31, 2019 - Conformis, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2019. Q2 Summary"
05/01/2019 8-K Quarterly results
02/06/2019 8-K Quarterly results
10/31/2018 8-K Quarterly results
Docs: "Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance BILLERICA, Mass., October 31, 2018 - Conformis, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2018. Q3 Summary"
08/01/2018 8-K Quarterly results
Docs: "Conformis Reports Second Quarter 2018 Financial Results BILLERICA, Mass., August 1, 2018 - Conformis, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2018. Q2 Summary"
05/02/2018 8-K Quarterly results
Docs: "CONFORMIS, INC. AND SUBSIDIARIES Consolidated Statements of Operations Three Months Ended March 31, 2018 2017 Revenue Product $ 19,483 $ 20,379 Royalty 173 76 Total revenue 19,656 20,455 Cost of revenue 10,869 13,960 Gross profit 8,787 6,495 Operating expenses Sales and marketing 10,411 10,816 Research and development 4,694 4,560 General and administrative 6,140 8,458 Total operating expenses 21,245 23,834 Loss from operations Other income and expenses Interest income 140 103 Interest expense Foreign currency exchange transaction income 1,085 390 Total other expenses 490 186 Loss before income taxes Income tax provision 33 7 Net loss $ $ Net loss per share - basic and diluted $ $ Weighted average common shares outstanding - basic and diluted 54,741,828 42,874,743"
02/07/2018 8-K Quarterly results
Docs: "ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance BILLERICA, Mass., February 7, 2018 - ConforMIS, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2017. Q4 Summary"
11/01/2017 8-K Quarterly results
Docs: "ConforMIS Reports Third Quarter 2017 Financial Results BILLERICA, Mass., November 1, 2017 -- ConforMIS, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2017. Q3 Summary:"
08/03/2017 8-K Quarterly results
Docs: "ConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance BILLERICA, Mass., August 3, 2017 -- ConforMIS, Inc. , a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2017. Q2 Summary:"
05/10/2017 8-K Form 8-K - Current report
02/15/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/08/2016 8-K Form 8-K - Current report
05/12/2016 8-K Form 8-K - Current report
02/11/2016 8-K Form 8-K - Current report
11/02/2015 8-K Form 8-K - Current report
08/11/2015 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy